A Phase I Clinical Study of HLX3902 in Patients With mCRPC and Other Advanced Tumours
A Phase I Clinical Study of HLX3902 in Patients With mCRPC and Other Advanced Tumours
Recruiting · NCT07533708 · Registry updated 2026-08-11Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase I Clinical Study of HLX3902 in Patients With mCRPC and Other Advanced Tumours | mCRPC or Advanced/Metastatic Solid Tumors | Recruiting | Phase 1 | 2026-08-11 | NCT07533708 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Shanghai Henlius Biotech | 58 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Fudan University Shanghai Cancer Center | Shanghai | China | 128 |
| Guangxi Medical University Cancer Hospital | Naning | China | 1 |
| Nanjing Drum Tower Hospital | Nanjing | China | 24 |
| The First Affiliated Hospital of Nanchang University | Nanchang | China | 55 |
| The First Affiliated Hospital of Xiamen University | Xiamen | China | 40 |